Reach Showcases Full-Stack Product Portfolio for AI Vehicle Intelligent Evolution at Auto China 2026
BEIJING, April 30, 2026 /PRNewswire/ -- At Auto China 2026, Reach officially unveiled its full-stack product portfolio designed to accelerate the intelligent evolution of AI vehicles. Industry leaders and experts, along with executives and...
LG ELECTRONICS PRESENTS HYBRID EMERGENCY CALL SOLUTION AT 5GAA IN SWEDEN
Enhancing Driver Safety, Hybrid eCall Enables Seamless Emergency Communication Across 2G to 5G Networks in Compliance with Europe's 2027 NG eCall Requirements News Summary LG Electronics showcased its Hybrid eCall solution at the 37th 5GAA Meeting...
Caliway's Fat Reduction Drug CBL-514 Phase 2 Clinical Results Accepted by ASJ. CBL-0204's Demonstrated Efficacy and Safety Gain Further Academic Recognition
Clinical results from Caliway's CBL-0204 Phase 2b study of its fat reduction drug candidate CBL-514 for localized fat reduction have been accepted by the Aesthetic Surgery Journal (ASJ), a leading academic journal in aesthetic medicine and plastic...
Hankook Strengthens Motorsport Presence at the 2026 Hi-Tec Oils Bathurst 6 Hour
Hankook proves its top-tier technological leadership by serving as the official tyre supplier to the 'Bathurst 6 Hour' for the second consecutive year Ventus TD delivered consistent grip, stability and durability across six hours of racing...
Gan & Lee Pharmaceuticals' Once-Weekly Basal Insulin GZR4 Injection Meets Primary Endpoints in Two Pivotal Phase 3 Clinical Trials: SUPER-1 and SUPER-2
BEIJING and BRIDGEWATER, N.J., March 31, 2026 /PRNewswire/ -- Gan & Lee Pharmaceuticals (SSE: 603087) today announced that two pivotal phase 3 clinical trials, SUPER-1 and SUPER-2, evaluating investigative once-weekly insulin GZR4 Injection,...
RoboSense Driving Ecosystem Deployment with Global Partners at NVIDIA GTC 2026
SHENZHEN, China, March 17, 2026 /PRNewswire/ -- RoboSense (HKEX: 2498), an AI-driven robotics technology company, today demonstrated the extensive commercial footprint of its collaboration with NVIDIA at GTC 2026. As a core partner across the NVIDIA...
HONOR Advances Its AI Vision at MWC 2026 with Robot Phone, Humanoid Robot and Magic V6
From robotics innovation to flagship devices, HONOR expands its AI device ecosystem at MWC 2026 BARCELONA, Spain, March 2, 2026 /PRNewswire/ -- At MWC 2026, HONOR advanced its Augmented Human Intelligence (AHI) vision and accelerated ALPHA PLAN...
Ascletis Announces Positive Topline Results from Its Phase III Open-Label Study of Denifanstat (ASC40), a First-in-Class, Once-Daily Oral FASN Inhibitor for Acne
- Denifanstat (ASC40), a once-daily oral fatty acid synthase (FASN) inhibitor, demonstrated favorable safety and tolerability in a Phase III open-label study - The exceptional efficacy of denifanstat (ASC40) observed in the Company's previously...
Kazia Therapeutics Reports Encouraging Preliminary Clinical Responses in Ongoing Phase 1b Study of Paxalisib in Late-Stage Metastatic Triple-Negative Breast Cancer
SYDNEY, Jan. 27, 2026 /PRNewswire/ -- Kazia Therapeutics (NASDAQ: KZIA), today provided a clinical update from its ongoing Phase 1b study evaluating paxalisib in combination with pembrolizumab and chemotherapy in patients with late-stage (Stage IV),...
e& and IBM Unveil Enterprise-Grade Agentic AI to Transform Governance and Compliance
Announced at the World Economic Forum in Davos, the deployment marks e&'s move beyond traditional chatbots to enterprise-grade agentic AI. Powered by IBM watsonx Orchestrate, agentic AI is embedded into mission-critical governance and compliance...